Baxter finds home for $1B biomanufacturing plant; Cubist's earnings pop on strong Cubicin sales;

 @FiercePharma: Baxter beats Wall Street projections but gets FDA questions on new treatment. Article | Follow @FiercePharma

> Baxter has selected a site in Georgia for a $1 billion project to produce plasma-based products. Article

> Cubist Pharmaceuticals' ($CBST) first quarter earnings jumped 45% after the company posted strong revenue from its lead antibiotic Cubicin. Item

> Global pharma revenue hit $707 billion in 2011, up 5.3% from 2010 with some help from positive currency effects for major drugmakers, market research firm Decision Resources found. Release

> Depomed is suing Watson Pharmaceuticals ($WPI), accusing it of infringing a patent covering Type 2 diabetes drug Glumetza. Release

Biotech News

 @FierceBiotech: Gilead wows analysts as 7977 combos quell hepC in most patients. Article | Follow @FierceBiotech

 @JohnCFierce: I've begun to put more thought into this year's Fierce 15. Not a bad time to start emailing me with suggestions. | Follow @JohnCFierce

 @RyanMFierce: Medivir's stock trading down after new TMC435 data in hepatitis C. In study, up to 80% cured. Disappointing? Article | Follow @RyanMFierce

> Alder broadens antibody work with $38M D round. Story

> GSK puts Human Genome Sciences in play with $2.59B buyout offer. News

​Medical Devices News

 @FierceMedDev: Interesting: Researchers Discover Non-Surgical Test for Brain Cancer - Release | Follow @FierceMedDev

> Stem cell startup SynGen scores $5M in Series A. Story

> Boston Sci sees earnings jump as sales slip. Report

> J&J gains EU nod for $21.3B Synthes deal. Item

> NeuroMetrix seeks 510(k) nod for pain therapy device. News

CRO News

> INC Research and Astellas expand alliance. Article

> Unsecured creditors get more time to bid on Cetero. News

> Moody's eyes investor backlash for InVentiv after CRO acquisitions. More

> Australia's vivoPharm grabs RMIT University drug discovery tech. Story

> Children's tastes overlooked in clinical trials. Item

Vaccine News

> Scancell's DNA melanoma vaccine poised for Phase II. Article

> Passive vaccine could treat cocaine overdose. News

> Personalized brain cancer vaccine improves survival. Story

> Study: Dengue virus research needs to focus on people, not mice. More

> DNA vaccine for prostate cancer moves into Phase III. Item

Pharma Manufacturing

> Baxter to erect $1B plasma plant. Story

> CSL recalling product tainted with ethylene glycol. Article

> U.S. Marshals seize ultrasound gel containing dangerous levels of bacteria. News

> J&J plant overhaul turning into 4-year project. More

And Finally... A paper published in Translational Psychiatry caused a commotion in the media about the "first blood test to diagnose depression in teenagers." But psychiatrists say much more data is needed before the test ends up in the clinic. News

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.